PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 1, 1984Archives of Ophthalmology206 citations

Selection of Therapeutic Agents for Intraocular Proliferative Disease

View Full Paper
MBMark S. Blumenkranz

Key Points

Key points are not available for this paper at this time.

Abstract

A variety of antimetabolites, steroids, and nonsteroidal anti-inflammatory agents were tested for their ability to inhibit rabbit dermal and conjunctival fibroblast proliferation in cell culture. Doxorubicin hydrochloride and fluorouracil produced notable inhibition in concentrations of less than 1 mg/L. Meclofenamate sodium and indomethacin produced notable inhibition at concentrations of 11 and 40 mg/L, respectively. Dexamethasone sodium phosphate and triamcinolone acetonide produced inhibition at 200 and 150 mg/L, respectively, but paradoxically increased proliferation almost two-fold at concentrations ranging from 1 to 30 mg/L under identical culture conditions. Methotrexate sodium demonstrated only limited effectiveness. This assay system may be a useful approach to drug selection in the treatment of a variety of ocular proliferative disorders. Fluorouracil may prove to be of significant value in the treatment of intraocular proliferative disorders.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Mark S. Blumenkranz (1984) studied this question.

synapsesocial.com/papers/6a7a35e5b008f0cadf325352https://doi.org/10.1001/archopht.1984.01040030470029
Ask AI
Helpful
Bookmark
Share
View Full Paper